LD-2 disclosure · 3rd Quarter - Report
ASTCT
Client
- Name
- ASTCT
- Description
- Healthcare Society
- Location
- District of Columbia · United States of America
Registrant
- Description
- Trade association
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
ASTCT Appropriations Billing and Coding CAR-T Therapy Clarifications Cures 2.0 Engagement Revaccination of Immunosuppressed Patients Covid funding Patient-Care Episode Financial Toxicity
LobbyistsALYCIA MALONEY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)
Medicare/Medicaid
- CMS coding and billing clarity for CAR-T therapies - CMS engagement and follow up on FY2021 new MS-DRG for CAR-T Therapies - Covid funding - Patient Care Episode - Financial Toxicity
LobbyistsALYCIA MALONEY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)
Medical/Disease Research/Clinical Labs
- Appropriations - CAR-T Therapy clarification - Cures 2.0 Engagement
LobbyistsALYCIA MALONEY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)